Skip to main content
low healthVERIFIED📡 SPREADING

Bayer reaches Roundup settlement that could cost the company billions

Verified: 9 outlets in 6 countries have reported this story since Nov 20, 3 of them from the United States.

🕐 3h ago·9 outlets

The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma – a blood cancer linked to the herbicide.

How sure are we

✓ Verified · 9 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

The story so far · 10 reports · · 6 countries✓ Verified Nov 20, 10:34 PM UTC

3 outlets from the United States, where the story is: Bloomberg, NPR News, The New York Times · how we count

  1. Nov 20, 10:32 PM UTCFirst report
    Bayer’s $7.25 Billion Roundup Settlement Approved by Judgebloomberg.com ↗
  2. Nov 20, 10:34 PM UTC+2 min
    Missouri judge approves Bayer’s $7.25 billion Roundup settlementinvesting.com ↗
  3. Verified: a second independent outlet reported itNov 20, 10:34 PM UTC · +2 min
  4. Nov 21, 12:08 AM UTC+2 h
    Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancertheguardian.com ↗
  5. Nov 21, 5:33 PM UTC+19 h
    Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancernytimes.com (again) ↗
  6. Nov 21, 8:56 PM UTC+22 h· you’re reading this
    Bayer reaches Roundup settlement that could cost the company billionsnpr.org ↗
  7. Nov 21, 9:54 PM UTC+23 h
    US judge approves $7.25b Roundup cancer settlementthedailystar.net ↗
  8. Nov 21, 11:38 PM UTC+25 h
    US court approves $7.25 billion settlement with Bayer over claims Roundup weed killer caused cancerjamaica-gleaner.com ↗
Verification Log

No verification data yet

Checks run automatically as new sources are ingested.

Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
96%

Very high · How we score this

Risk Score
low risk